Results 151 to 160 of about 2,347 (191)
Molecular mechanisms of tumor-associated macrophages in hepatocellular carcinoma development and therapy. [PDF]
World J GastroenterolYang M, Zhang CY.
europepmc +1 more source
Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention. [PDF]
NutrientsTobaruela-Resola AL +10 more
europepmc +1 more source
Performance prediction equation for the Valencia Marathon based on time and pacing in the half marathon. [PDF]
Front PhysiolOficial-Casado F +2 more
europepmc +1 more source
Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer, 2013 Effective cancer biomarkers for early detection, prognosis, or therapy response prediction are urgently need in metastatic RCC. M30 and M65 are released during apoptotic cell death and precisely reflect epithelial tumor cell death. The aim of this study was to determine the prognostic value of plasma M30 and M65 levels in predicting survival rates for ...
Ibrahim Yıldız +2 more
exaly +4 more sources
Cancer Chemotherapy and Pharmacology, 2013 This study was conducted to determine the clinical significance of serum M30 and M65 in epithelial ovarian cancer (EOC).A total of 56 patients with EOC and 56 healthy women were included in the study. All of the patients received platinum-based chemotherapy. Pretreatment levels of M30 and M65 were measured using the quantitative ELISA method.The median
Ibrahim Yıldız +2 more
exaly +4 more sources
Clinical significance of serum M30 and M65 levels in melanoma
Melanoma Research, 2013 M30 and M65 are relatively new assays that detect different circulating forms of the epithelial cell structural protein cytokeratin 18. This study was carried out to investigate the serum levels of M30 and M65 in patients with melanoma and the relationship with tumor progression and known prognostic parameters.
Faruk, Tas +6 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC
Clinical and Translational Oncology, 2016Paclitaxel is an effective treatment for some of the non-small-cell lung cancer (NSCLC) patients. However, prediction of the outcome of paclitaxel treatment at the early stage of the chemotherapy is difficult. M30 and M65 are circulating fragments of cytokeratin 18 released during apoptosis or necrosis, respectively, and have been used as markers to ...
T Chu, W Ying, Han B
exaly +3 more sources
Current Problems in Cancer, 2020
M30 and M65 levels reflect tumor cell activity in patients with epithelial cancer. Cytokeratin 18 is one of the cell skeletal elements. M30 is a apoptotic marker of cytokeratin 18. M65 levels are both an apoptosis and a necrosis marker. The aim of our study was to determine the predictive value of M30 and M65 levels in neoadjuvant treatment of breast ...
Altay Aliyev +2 more
exaly +4 more sources
M30 and M65 levels reflect tumor cell activity in patients with epithelial cancer. Cytokeratin 18 is one of the cell skeletal elements. M30 is a apoptotic marker of cytokeratin 18. M65 levels are both an apoptosis and a necrosis marker. The aim of our study was to determine the predictive value of M30 and M65 levels in neoadjuvant treatment of breast ...
Altay Aliyev +2 more
exaly +4 more sources
Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors
International Immunopharmacology, 2009M30-Apoptosense and M65 ELISAs can detect caspase cleaved and intact forms of cytokeratin 18. As biologic marker of cell death, both assays can be useful to evaluate prognosis and chemotherapy response in the patients with breast, lung, and endometrium cancer.
Banu ÖZTÜRK +2 more
exaly +4 more sources